Yuria Ablanedo-Terrazas, Oscar Estrada-Camacho, Claudia Alvarado-de la Barrera, Arturo Ramírez-García, Gabriel Tona-Acedo, Daniel Bross-Soriano, José Schimelmitz-Idi
OBJECTIVES: After surgical resection of papilloma, adjuvant therapy may be recommended for the control of recurrent respiratory papillomatosis (RRP). As the efficacy of adjuvant therapy remains unproven, the aim of this study was to compare the efficacy of cidofovir versus bevacizumab used as adjuvant therapies for the control of RRP. METHODS: This randomized, double-blind, placebo-controlled pilot study was performed in a national respiratory disease referral centre...
June 18, 2021: Acta otorrinolaringologica española